Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ascletis has announced the selection of ASC35, a best-in-class once-monthly subcutaneous GLP-1R/GIPR dual peptide agonist, advancing toward clinical development for obesity and metabolic diseases
Contact us today Personalized plans by clinical experts In-depth diagnostic testing before treatment begins Ongoing support for lasting results We start with advanced testing, turn your data into a personalized plan, and track progress to keep you improving
Key facts for patients: Approved December 22, 2025
E., & Katzinger, J
US$ 23.12
US$ 23.11
US$ 21.17
US$ 29.21
US$ 29.46
US$ 20.31
US$ 23.07
US$ 22.99
US$ 23.21
